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ABSTRACT
Background: The prevalence, pathology, and existence of
malnutrition-associated diabetes remain uncertain, especially
with respect to adult-acquired undernutrition.
Objective: The aim was to investigate the association of prior
undernutrition (low BMI, in kg/m2), acquired in adulthood and
insulin during an oral glucose tolerance test (OGTT).
Methods: We followed up 630 adults recruited 7–14 y previously
for other studies. Plasma insulin was measured fasting and at 30 and
120 min during an OGTT. The main exposure was BMI measured
7–14 y prior. The main outcome of interest was plasma insulin,
controlling for time during the OGTT using generalized estimating
equations, and exploratory outcomes were early insulin response
(relative change in insulin and glucose from 0–30 min) and relative
insulin and glucose AUCs from 0 to 120 min. Current confounding
factors were age, sex, BMI, HIV, socioeconomic status, and physical
activity.
Results: In unadjusted analyses, increasing severity of prior
malnutrition was associated with lower insulin concentration. In
multivariate adjusted analyses, only current BMI was a strong
predictor of overall insulin concentration. Associations with prior
BMI of insulin responses accounting for glucose were also seen in
unadjusted but not adjusted analyses. For insulin concentration but
not the outcomes accounting for glucose, there was a sex interaction
with prior BMI such that only men had lower insulin if previously
malnourished: insulin (pmol/L) at 120 min was 311 (95% CI: 272,
351) for prior BMI ≥18.5, 271 (95% CI: 221, 321) for prior BMI
17.0–18.5, and 237 (95% CI: 194, 297) for prior BMI <17.0;
P = 0.03. HIV status showed limited and variable associations with
insulin.
Conclusions: Insulin concentration, fasting and during an OGTT,
was normalized in women more than in men several years after
adult malnutrition. Chronic malnutrition, as indicated by low prior
and current BMI, may contribute to diabetes through low insulin
secretion. Am J Clin Nutr 2021;00:1–9.
Keywords: malnutrition-associated diabetes, HIV, Tanzania, in-
sulin, glucose tolerance
Introduction
Most cases of diabetes now occur in low- and middle-income
countries (LMICs) (1), where diabetes tends to occur at relatively
low age and BMI (in kg/m2) (2, 3). There are heterogeneous
reports of atypical diabetes in LMICs, describing an entity of
malnutrition-related, insulin-deficient diabetes related to pancre-
atic damage (4). Although malnutrition-associated diabetes was
previously included as an official category of diabetes (5), it is
not a currently recognized category (4).
Despite the rising prevalence of overweight in LMICs,
malnutrition as indicated by wasting remains prevalent in young
children (6) and also frequently occurs in adults in associa-
tion with severe infections, particularly HIV and tuberculosis.
Childhood malnutrition has been identified as a risk factor
for diabetes among Ethiopian adults (7). Exposure to famine
during childhood was associated with increased adult diabetes
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in the Netherlands (8) and China (9). The Chinese study found
that higher BMI or consumption in adulthood of a typically
Western dietary pattern, rather than the traditional diet, increased
the risk of hyperglycemia among those previously exposed to
famine (9). Adult Jamaican survivors of childhood marasmus,
compared with never malnourished controls, had more glu-
cose intolerance, lower insulin secretion, and reduced insulin
sensitivity (10).
Malnutrition in adulthood may also alter endocrine pancreatic
function: among HIV-infected Tanzanian adults who started
antiretroviral therapy (ART) when malnourished, those with the
lowest fat mass either at the start of ART or 2–3 y later had the
highest risk of new-onset diabetes (11). Patients with anorexia
nervosa who have recovered nutritionally have been found to
have impaired glucose tolerance and a delayed and lower insulin
response than controls (12). The similarity between previously
malnourished Tanzanians, with or without HIV or ART, and
patients with anorexia nervosa who demonstrate an almost
exclusively nutritional deficit lends support to the hypothesis that
adult malnutrition itself has long-term effects on the pancreas
with lower insulin production.
The Chronic Infections, Comorbidities, and Diabetes in Africa
(CICADA) study is a cohort study investigating the burden
of and risk factors for diabetes among adults in Mwanza,
Tanzania. Some study participants come from our prior research
on nutritional interventions for HIV or tuberculosis, and we
thus know their nutritional status from several years previous
when many were malnourished, as indicated by low BMI. In this
secondary analysis, we used data from the cohort to investigate




The CICADA study is registered at clinicaltrials.gov as
NCT03106480, and the cohort for this study investigating
diabetes and its interactions with infections has been previously
described (13). Briefly, the cohort comprised 3 groups of adults
>18 y of age: 1) participants of Nutrition, Diabetes, and Pul-
monary Tuberculosis (TB-NUT; https://clinicaltrials.gov/ct2/sho
w/NCT00311298), a nutritional supplementation trial conducted
in Mwanza in 2006–2009 among tuberculosis-infected and
uninfected adults (14–17); 2) participants of Nutritional Support
for African Adults Starting Antiretroviral Therapy (NUSTART;
Tanzanian site), which tested the effects of adding vitamins and
minerals to a lipid-based nutritional supplement on morbidity
and mortality of malnourished HIV-infected participants starting
ART, conducted from August 2011 to December 2013 (18),
registered at the Pan African Clinical Trial registry (https://pa
ctr.samrc.ac.za/Search.aspx) as PACTR201106000300631; and
3) a new cohort comprising newly diagnosed HIV-infected,
ART-naive participants from ART clinics in Mwanza and HIV-
uninfected controls from the neighborhoods of the new HIV
cohort participants. For the present analyses, we did not include
the new cohort for whom we have no data on prior nutritional
status. Methods and results concerning diabetes prevalence in
the full CICADA cohort are published (13), and the flowchart
of participants from prior studies included in this analysis is in
Supplemental Figure 1.
Ethics
The study was conducted in accordance with the Declaration
of Helsinki of 1975, as revised in 1983. Ethical clearance was
provided by the Medical Research Coordinating Committee of
the National Institute for Medical Research in Tanzania and the
London School of Hygiene and Tropical Medicine in United
Kingdom, and consultative approval was obtained by the National
Committee on Health Research Ethics in Denmark. Participants
were enrolled after written informed consent, and those with
diabetes and other illnesses were referred to Sekou-Toure referral
hospital for care.
HIV and tuberculosis assessment and treatment
HIV status was determined when the participants were
recruited for the prior studies using 2 different rapid antibody
tests: Determine HIV-1/2 (Inverness Medical Japan, Abbot) and
Capillus HIV-1/2 (Trinity Biotech). Discordant samples were
tested using the Uniform II Vironostika-HIV Ag/Ab Micro-
ELISA system (Biomerieux BV). When recruited to CICADA,
HIV-infected participants had been on ART for a median of 53 mo
(IQR: 46, 102 mo). About half of the HIV-infected participants
were taking azidothymidine-based regimens, and half received
tenofovir-based regimens; participants taking different ART
regimens had similar diabetes prevalence (13).
In TB-NUT, tuberculosis was diagnosed using a combination
of clinical symptoms, sputum microscopy, and chest X-ray (15).
Tuberculosis was not the focus of NUSTART, and we considered
people as having tuberculosis if they were on tuberculosis
treatment, given by non-study doctors, prior to starting ART (19).
In both studies, patients diagnosed with tuberculosis received 6
mo of treatment according to Tanzanian and WHO guidelines.
Because of this major difference in tuberculosis diagnostic
methods and since all tuberculosis treatments ended many years
before the current CICADA study, tuberculosis was not included
in statistical analyses.
Anthropometry
In both of the earlier studies, TB-NUT and NUSTART, and
for CICADA, height and weight were measured by trained
staff at enrollment using standard methods (20). Means of
duplicate measures (TB-NUT) or medians of triplicate measures
(NUSTART and CICADA) were used to calculate BMIs.
Diabetes and insulin assessment
Diabetes was assessed in 2 ways: by glycated hemoglobin
(HbA1c) measured on a point-of-care analyzer (HemoCue
201RT) and by a standard 2-h oral glucose tolerance test (OGTT)
in which participants who had fasted overnight were given
82.5 g dextrose monohydrate (equivalent to 75 g anhydrous
glucose) diluted in 250 mL of drinking water to drink within
5 min. Blood samples were collected for plasma glucose and
insulin assessment at baseline and 30 and 120 min. Glucose






/ajcn/advance-article/doi/10.1093/ajcn/nqaa438/6178919 by guest on 31 M
arch 2021
Prior malnutrition and insulin production 3
a commercial ELISA kit (ALPCO). WHO cutoffs were used to
diagnose diabetes and prediabetes (21). For HbA1c, prediabetes
was defined as 5.7% to <6.5% (39 to <48 mmol/mol), and
diabetes was defined as ≥6.5% (≥48 mmol/mol). For OGTT,
a 120-min glucose concentration between 7.8 and 11.1 mmol/L
was defined as prediabetes, and ≥11.1 mmol/L indicated
diabetes.
Statistical analyses
Analyses were conducted using Stata 16 (StataCorp). We used
a significance level of 0.05 without adjustment for multiple
testing as our analysis was exploratory. BMI in prior studies,
the main exposure in the current analysis, was categorized as
severely malnourished if BMI (in kg/m2) was <17.0, moderately
malnourished if BMI was 17.0–18.5, and not malnourished
if BMI was >18.5. At CICADA recruitment and OGTT
assessment, when participants were less malnourished than
in prior studies, BMI was categorized as malnourished if
<18.5, normal if BMI was 18.5–25.0, and overweight if BMI
was >25.
The main outcome of interest was insulin production, which
we measured by plasma insulin concentrations during the OGTT
conducted at CICADA recruitment. Insulin was analyzed using a
generalized linear model with γ distribution and log-link function
for positively skewed data and generalized estimating equations
(GEEs) with an unstructured covariance matrix to account for
within-person correlations of insulin concentrations at the 3 time
points. Models included a time factor since fasting, early (30
min) insulin, and later (120 min) insulin indicate different phases
of insulin secretion (22). In addition, to account for the fact
that insulin production is related to blood glucose, we used
the early 30-min insulin response (EIR), defined as (insulin30 –
insulin0)/(glucose30 – glucose0), and the ratio of the total areas
under the curves between 0 and 120 min of insulin/glucose
(AUC_IG) as exploratory outcomes (23). EIR and AUC_IG were
analyzed using general linear regression with gamma distribution
and log-link function for positively skewed data.
We conducted a complete case analysis removing those
missing glucose or insulin results or covariates at any of the
3 time points. We first conducted unadjusted analyses for
the main exposure and key outcomes. We then investigated
factors that might interact with prior BMI in associations with
insulin concentrations. Because HIV can cause malnutrition and
since both may be associated with increased risk of diabetes
or severity of its complications (13, 24–26), we investigated
whether there was an interaction between HIV status and prior
BMI. Because sex is associated with many aspects of nutrition
and chronic diseases, we investigated interactions of sex with
prior malnutrition. We investigated the interaction between prior
and current BMI based on follow-up studies of people who
experienced famine in childhood, which found that risk of
hyperglycemia was greater in those with subsequent high BMI
or Western-style diet (9).
We then conducted adjusted analyses including current age
(in 10-y bands), sex, HIV status (infected and taking ART or
uninfected), current BMI (in categories listed above), current
socioeconomic (SES) quintiles based on an asset index (13), and
current physical activity, based on self-report using the WHO
Global Physical Activity Questionnaire and its cutoff indicating
adequate activity of >600 Metabolic Equivalent of Task (MET)-
min per week (27). These factors were associated with either
diabetes or insulin production (13) (and not shown); other
lifestyle factors (smoking; consumption of fruits and vegetables,
as indicated by FFQ; or alcohol) were found previously not to be
associated with diabetes in the CICADA cohort (13). We assessed
collinearity using scatterplots and by comparing the standard
errors of adjusted models with unadjusted models; if the standard
errors in the adjusted models were not larger than the unadjusted
models, we assumed that no collinearity was present.
Results
Twenty-eight of the 658 potential participants had incomplete
glucose or insulin data for the 3 time points during the OGTT
(Supplemental Figure 1); therefore, the analyses included 630
participants, 428 from TB-NUT and 202 from NUSTART.
Compared with the full original cohorts, those recruited to
CICADA differed slightly in that those still available for
CICADA were older, more likely to be female, and less ill in the
prior studies as indicated by CD4 count, hemoglobin, or BMI
(Supplemental Table 1). Death during or since the previous
study was a major cause of loss to follow-up, especially in
NUSTART, where male sex, low CD4 count, and low BMI were
risk factors for mortality (28).
The groups defined by whether or not they had been previously
malnourished differed in several respects (Table 1). Those not
previously malnourished were older, of higher SES, of higher
current BMI, less likely to be HIV-infected, and less likely to
have had tuberculosis in the prior study. There was no difference
between groups in prevalence of diabetes and prediabetes
assessed by either OGTT or HbA1c, and prevalence in all
groups was quite high. A considerable number of participants had
changed BMI category since their previous assessment: 20 people
(7%) who were not malnourished in the prior studies had BMI
<18.5 at OGTT assessment, whereas most people previously
malnourished had normal BMI at this time.
Figure 1 shows crude geometric mean concentrations of
plasma glucose and insulin at the 3 time points in the OGTT.
Glucose differed according to prior malnutrition at time 0 only
(Wald P = 0.005), that is, glucose concentrations resolved
normally during the OGTT. Insulin results are expressed as
marginal means (95% CIs) from GEEs. Increasing severity of
prior malnutrition, as indicated by BMI, was associated with
lower plasma insulin at all time points in univariable analysis
(Table 2). Higher current BMI was associated with higher insulin
at all 3 time points and positive HIV status with lower insulin at
120 min only. Increasing age and male sex were associated with
lower insulin and increasing SES with higher insulin at all time
points (data not shown).
There was some evidence of an interaction between prior BMI
and sex (Wald P value at time 120 min was 0.019, but joint
interaction test for all times together had P = 0.21) in their
association with plasma insulin, controlling for time using GEEs.
Therefore, adjusted analyses were conducted stratified by sex
(Table 3). Current BMI was strongly and positively associated
with insulin concentration at all time points in both men and
women but prior BMI only in men at 120 min. In addition to men
having overall lower plasma insulin (P = 0.005), the reduction
in insulin associated with low prior BMI appeared greater in men
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BMI <17.0 P value
Number 292 171 167
Sex, female 155 (53) 86 (50) 100 (60) 0.19
Age group, y
18–29 20 (7) 10 (6) 14 (8)
30–39 57 (20) 54 (32) 40 (24) <0.001
40–49 90 (31) 69 (40) 62 (37)
≥50 125 (43) 38 (22) 51 (31)
HIV-infected 89 (30) 136 (80) 134 (80) <0.001
Tuberculosis-infected in prior study2 118 (41) 79 (46) 92 (55) 0.02
SES quintile
Lowest 59 (20) 52 (31) 61 (37)
Low 48 (16) 41 (24) 37 (22) <0.001
Middle 54 (18) 32 (19) 26 (16)
High 57 (20) 20 (12) 22 (13)
Highest 74 (25) 25 (15) 21 (13)
Current BMI, kg/m2, mean ± SD 24.2 ± 4.9 20.2 ± 3.0 19.4 ± 2.6 <0.001
Current BMI group, kg/m2
<18.5 20 (7) 54 (32) 67 (40) <0.001
18.5–25.0 160 (55) 107 (63) 96 (57)
>25.0 112 (38) 10 (6) 4 (2)
Diabetes by OGTT
Normal 141 (48) 83 (49) 92 (55)
Prediabetes 133 (46) 84 (49) 67 (40) 0.20
Diabetes 18 (6) 4 (2) 8 (5)
Diabetes by HbA1c
Normal 223 (76) 129 (75) 124 (75)
Prediabetes 43 (15) 32 (19) 28 (17) 0.65
Diabetes 26 (9) 10 (6) 14 (8)
1Values are presented as number (%) unless otherwise indicated. P values are from the χ2 test for categorical
variables, analysis of variance for current BMI (in kg/m2). HbA1c, glycated hemoglobin where normal <5.7%,
prediabetes 5.7–6.5%, and diabetes >6.5%; OGTT, 2-h oral glucose tolerance test where, for glucose at 120 min,
normal <7.8 mmol/L, prediabetes 7.8–11.1 mmol/L, and diabetes >11.1 mmol/L; SES, socioeconomic status
according to an asset index.
2Prior tuberculosis infection data missing for 3 Nutritional Support for African Adults Starting Antiretroviral
Therapy (NUSTART) participants. In Nutrition, Diabetes, and Pulmonary Tuberculosis (TB-NUT), tuberculosis was
diagnosed by the study team using clinical signs and sputum tests, whereas in NUSTART, diagnoses were by nonstudy
clinicians, and tuberculosis infection for study purposes was defined as taking tuberculosis medication before starting
antiretroviral therapy.
There was no evidence of a similar interaction of prior BMI
with HIV status (Wald P value joint test for interaction at
each time was 0.92) (Supplemental Table 2). There was weak
evidence for an interaction between prior BMI and current BMI
(Wald P value joint test for interaction at each time was 0.07),
but numbers in some subgroups divided according to prior and
current BMI were too small for robust estimates (Supplemental
Table 2).
For 78 participants (12%), the EIR (i.e., the ratio of the change
in insulin over the change in glucose from baseline to 30 min)
was negative, mainly because of a negative change in glucose
(63 participants) or undefined (n = 8) due to zero change in
glucose over 30 min. These participants were excluded from the
EIR analyses. No differences were observed by age, sex, HIV
status, current BMI, SES, or fasting insulin comparing those with
negative or undefined EIR with those included in EIR analysis;
however, those excluded from EIR analysis had a higher mean ±
SD fasting glucose: 8.2 ± 2.4 mmol/L compared with 6.7 ± 1.3
mmol/L for those included, P < 0.001.
Table 4 shows marginal means from unadjusted and adjusted
analyses of EIR and AUC_IG from generalized linear models.
For these 2 outcomes, the association with prior malnutrition
was modified by current BMI (P for interaction = 0.03); the
interaction term was included in the analysis, but separate
marginal means are not presented due to very low sample sizes
in some cells. There was no evidence that prior malnutrition
was associated with EIR, although mean values were lower
among previously malnourished people. Higher current BMI was
associated with higher EIR. Being HIV-positive was associated
with lower EIR in unadjusted but not adjusted analyses. For
AUC_IG, prior malnutrition was associated with lower values in
univariable but not adjusted analyses, current BMI was positively
associated in both, and HIV status was associated in neither.
Discussion
In univariable analyses, prior malnutrition in adults, especially
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FIGURE 1 Geometric mean values of glucose and insulin during an oral glucose tolerance test according to prior BMI (in kg/m2). There were 292
participants with prior BMI >18.5, 171 with prior BMI 17.0–18.5, and 167 with prior BMI <17.0. Glucose differed among prior malnutrition groups only at
time 0; Wald P = 0.005. Insulin differed among groups at all times: times 0 and 120 min, P < 0.001; time 30 min, P = 0.06.
was associated with lower plasma insulin and insulin indices
during an OGTT compared with people not previously mal-
nourished. However, in adjusted analyses, this association of
prior BMI and insulin concentrations and indices was generally
not significant. Men appeared at greater risk than women
of low insulin concentration if they had previously been
malnourished.
Other studies have shown differing risk of impaired glucose
metabolism in men and women following recovery from
malnutrition. Among men and women exposed to famine in
Austria, men were at greater risk of developing diabetes than
women after in utero or early life undernutrition (29). After
exposure to famine during fetal or infant life in Nigeria, men
were at higher risk of impaired glucose tolerance, as assessed
by random plasma glucose, but women were at greater risk of
overweight (30). This excess risk of overweight in women has
also been seen after childhood malnutrition in South Africa (31).
In most of Africa, as well as in the CICADA cohort (see sample
sizes in Table 3), women are more likely than men to have
BMI in the overweight range (32). Greater risk of overweight
among women is one of multiple interacting mechanisms
that contribute to sex differences in diabetes prevalence and
complications in high-income situations where overweight is
prevalent and prior malnutrition is rarely a concern (33). Sex
differences in response to prior malnutrition associated with
infections may further complicate the picture. In both Africans
TABLE 2 Plasma insulin (pmol/L) during an oral glucose tolerance test according to current and prior BMI and HIV
status1
Risk factor n Baseline 30 min 120 min
Prior BMI,2 kg/m2
>18.5 292 53 (47, 58) 368 (336, 401) 343 (312, 375)
17.0–18.5 171 41 (37, 45) 324 (285, 364) 263 (229, 296)
<17.0 167 40 (37, 44) 312 (272, 352) 226 (205, 247)
P value <0.001 0.06 <0.001
Current BMI,3 kg/m2
>25.0 126 78 (68, 88) 520 (453, 586) 469 (412, 527)
18.5–25.0 363 42 (39, 44) 313 (290, 337) 260 (241, 279)
<18.5 141 29 (25, 32) 255 (225, 284) 207 (181, 234)
P value <0.001 <0.001 <0.001
HIV status4
Negative 271 47 (42, 52) 346 (314, 379) 326 (294, 358)
Positive 359 46 (42, 49) 338 (309, 366) 263 (242, 285)
P value 0.75 0.69 0.001
1Values are marginal means (95% CIs) from general estimating equations using a log link and γ distribution with
unstructured covariance matrix and robust standard errors adjusting for time.
2P values of overall effects: time, P < 0.001; prior BMI, P < 0.001.
3P values of overall effects: time, P < 0.001; current BMI, P < 0.001.
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TABLE 3 Adjusted analysis of plasma insulin (pmol/L) during an oral glucose tolerance test1,2
Risk factor n Baseline 30 min 120 min
Women
Prior BMI, kg/m2
>18.5 155 49 (44, 54) 356 (315, 397) 286 (250, 323)
17.0–18.5 86 51 (44, 58) 374 (310, 438) 346 (283, 409)
<17.0 100 53 (47, 60) 374 (322, 427) 293 (255, 331)
P value 0.57 0.87 0.20
Current BMI, kg/m2
>25.0 95 77 (63, 91) 500 (405, 594) 430 (349, 511)
18.5–25.0 183 47 (43, 50) 338 (306, 369) 271 (244, 297)
<18.5 63 36 (30, 41) 310 (257, 362) 262 (209, 314)
P value <0.001 0.001 <0.001
Men
Prior BMI, kg/m2
>18.5 137 41 (37, 46) 318 (280, 357) 311 (272, 351)
17.0–18.5 85 43 (37, 50) 351 (291, 411) 271 (221, 321)
<17.0 67 42 (34, 49) 325 (241, 408) 237 (194, 297)
P value 0.85 0.58 0.03
Current BMI, kg/m2
>25.0 31 78 (63, 93) 553 (407, 700) 453 (337, 570)
18.5–25.0 180 36 (33, 39) 283 (251, 316) 244 (219, 268)
<18.5 78 24 (20, 27) 230 (193, 268) 208 (171, 244)
P value <0.001 <0.001 <0.001
Combined sexes
HIV status
Negative 271 43 (39, 46) 323 (296, 351) 295 (269, 321)
Positive 359 49 (46, 53) 360 (330, 391) 288 (263, 312)
P value 0.01 0.09 0.69
1Values are marginal means (95% CIs) from general estimating equations using a log link and γ distribution with
unstructured covariance matrix and robust standard errors adjusting for time; confounders included are age,
socioeconomic quintile, and whether or not physical activity was greater or less than 600 Metabolic Equivalent of
Task (MET)-min per week.
2P value for overall effect of sex = 0.002; P value for joint sex × time × prior malnutrition = 0.16; P value for
overall effect of time = <0.001; P value for overall effect of prior malnutrition = 0.549; P value for overall effect of
current BMI = <0.001; P value for overall effect of HIV status = 0.107.
and Americans, HIV infection was associated with greater loss
of fat-free mass in men than in women (34). Among Africans
with tuberculosis-associated wasting, men gained more lean
mass and women more fat mass during treatment (35, 36).
Furthermore, there may be a sex differential in survivor bias
after severe malnutrition: men in the NUSTART study, one
component of the CICADA cohort, were more likely to die
soon after recruitment to NUSTART (28), and males were
FIGURE 2 Marginal mean insulin concentrations of women and men during an oral glucose tolerance test according to prior BMI (in kg/m2). Values are
marginal means from univariable analysis using generalized estimating equations to control for time point during the test. There were 155 female and 137 male
participants with prior BMI >18.5, 86 women and 85 men with prior BMI 17.0–18.5, and 100 women and 67 men with prior BMI <17.0. Prior BMI was
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TABLE 4 Early insulin response and the ratio of the AUC from 0 to 120 min for insulin over the AUC for glucose1
Characteristic n Unadjusted Adjusted
Early insulin response N
Prior BMI, kg/m2
>18.5 253 317 (217, 417) 264 (181, 347)
17.0–18.5 155 217 (170, 263) 200 (153, 247)
<17.0 144 214 (144, 283) 166 (124, 208)
P value 0.11 0.39
Current BMI, kg/m2
>25.0 111 481 (264, 698) 227 (166, 288)
18.5–25.0 318 216 (176, 255) 189 (153, 225)
<18.5 123 184 (136, 232) 205 (138, 271)
P value 0.001 <0.001
HIV status
Negative 235 331 (220, 442) 219 (171, 268)
Positive 317 211 (178, 244) 194 (154, 234)
P value 0.02 0.33
Ratio of insulin to glucose AUC
Prior BMI, kg/m2
>18.5 292 49 (45, 53) 47 (42, 52)
17.0–18.5 171 42 (37, 47) 48 (42, 55)
<17.0 167 39 (35, 43) 46 (40, 52)
P value 0.004 0.82
Current BMI, kg/m2
>25.0 126 68 (60, 76) 66 (56, 77)
18.5–25.0 363 40 (38, 43) 42 (38, 46)
<18.5 141 34 (30, 37) 38 (33, 42)
P value <0.001 <0.001
HIV status
Negative 271 47 (42, 51) 46 (40, 51)
Positive 359 43 (39, 46) 49 (44, 54)
P value 0.14 0.27
1Early insulin response = change in insulin 0–30 min/change in glucose 0–30 min. AUC ratio = AUC insulin
0–120 min/AUC glucose 0–120 min. Original units were mmol/L for glucose and pmol/L for insulin. Values are
marginal means (95% CIs). Adjusted models included all variables shown plus age, sex, socioeconomic quintile, and
whether or not physical activity was greater or less than 600 Metabolic Equivalent of Task (MET)-min per week. The
interaction term for EIR and current BMI, P = 0.03, is included. Interaction terms for AUC ratio with sex, HIV status,
or current BMI and for EIR with sex or HIV status were not significant or included.
less likely to survive famine in China (37). These competing
sex associations of prior and current BMI and diabetes and
their potential effects on both pancreas function and peripheral
insulin resistance may have contributed to inconsistencies in
the literature as to whether or not prior malnutrition increases
the risk of later diabetes. It will be important for future
studies in the field to stratify data by sex and investigate
mechanisms.
HIV infection, all treated with ART in the current cohort,
was generally not associated with insulin production. We
previously found that any increases in diabetes risk in HIV-
infected participants in the CICADA cohort were associated with
inflammation-related insulin resistance in ART-naive patients, so
it appears that this, rather than decreased insulin production, is
key (13). Larger proportions of both the previously malnourished
groups (Table 1) and the HIV-infected participants (13) had
current BMI <18.5 or were in the lowest socioeconomic quintile
compared with the other groups. In a previous study, HIV-
infected Ethiopian adults not taking ART had lower plasma
insulin both fasting and during the OGTT than in our study, but it
is notable that BMI in that group was lower than in the CICADA
cohort (38). Thus, it seems that associations of low prior BMI, in
most cases in the CICADA population in association with HIV or
tuberculosis, with low plasma insulin could be due to prolonged
undernutrition or other factors associated with poverty. This is an
important area for further research since both food insecurity and
environmental enteropathy remain common in much of Africa
(39).
We compared several different markers of insulin
production—plasma insulin during fasting, both early and
later in the OGTT response, the EIR, and the area under the
curve in relation to glucose from baseline to 120 min—and all
gave similar overall results. This strengthens confidence that the
results reflect the underlying metabolism. We found differences
in insulin concentrations according to several factors, but the
values remained within the normal ranges (40), indicating no
profound impairment in insulin production or secretion, as found
in type 1 diabetes. However, a low insulin secretion capacity
could increase risk of developing diabetes if challenged by
insulin resistance from unhealthy diets or decreased physical
activity as seen during the nutrition transition (41). We note
that people with high BMI in our cohort had higher insulin
production but unchanged glucose disposal during the OGTT,
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U-shaped relation whereby both high and low BMI contribute to
the increasing prevalence of diabetes in countries undergoing the
nutrition transition. We are not certain why we found a higher
proportion of participants with negative or undefined (due to no
change in glucose) values of EIR compared with proportions
found by others (23, 42). The higher baseline glucose in this
group suggests some participants may not actually have been
fasting.
Major strengths of the study included its large sample size
and assessment of insulin responses by several methods. A
major limitation was that the CICADA cohort was not randomly
selected from the local population, which limits our ability
to generalize. Furthermore, there were high mortality rates in
the previous studies from which participants were recruited,
especially NUSTART, in which both low BMI and male sex were
risks for mortality (18, 28), so our data have a survivor bias;
although our adjusted models did control for these and other
factors, there remains the possibility of residual confounding. We
did not adjust for multiple testing in our exploratory analyses,
so it would be important to investigate these outcomes further
in future studies. Finally, we lack data on prior malnutrition in
utero or childhood, both of which may affect diabetes risk, in the
participants (7, 9, 10).
In conclusion, prior malnutrition alone is not a major driver of
impaired insulin production but may contribute to it, especially
in men. However, chronic undernutrition is associated with low
insulin production, and men who experienced severe malnutrition
may develop persistent low insulin production even if their weight
returns to normal. In people with HIV, chronic malnutrition
may explain in part why diabetes is sometimes more prevalent
among HIV-infected than uninfected people in addition to other
factors such as chronic inflammation and immune activation. In
Tanzania, where current and prior undernutrition is common,
more attention needs to be paid to insulin production in the
clinical management of diabetes. If there is a U-shaped relation
between BMI and diabetes, and the pathophysiologic pathway
is completely different for low and high BMI (insulin secretion
compared with resistance), this may have a major impact when
treating diabetes since in Africa, the usual first-line treatment,
metformin (2), does not address a key problem of reduced insulin
secretion.
The authors’ contributions were as follows—SF and AMR: conducted sta-
tistical analyses. SF: drafted the manuscript and takes primary responsibility
for its content; and all authors: were involved in conception of the analysis and
development of the research plan, contributed to the writing, and approved the
final manuscript. All authors are collaborators on the main CICADA study
for which GP is principal investigator. Additional CICADA investigators who
contributed to overall study design and data collection are H Friis, N Range, B
Kitilya, BB Kavishe, K Ramaiya, J Changalucha, MF Olsen, DC Heimburger,
AB Andersen, H Grewal, and J Kamwela.
Author disclosure: The authors report no conflicts of interest.
Data Availability
Deidentified data described in the manuscript can be made
available upon request to the authors and pending acceptance of a
data transfer agreement, according to ethical and other approvals
of the CICADA study.
References
1. World Health Organization. Diabetes 2020 [Internet]. Available from:
https://www.who.int/health-topics/diabetes.
2. Kibirige D, Lumu W, Jones AG, Smeeth L, Hattersley AT, Nyirenda
MJ. Understanding the manifestation of diabetes in sub Saharan Africa
to inform therapeutic approaches and preventive strategies: a narrative
review. Clin Diabetes Endocrinol 2019;5:2.
3. Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and
differences with populations in Europe and the United States. Ann NY
Acad Sci 2013;1281:64–91.
4. Bavuma C, Sahabandu D, Musafiri S, Danquah I, McQuillan R, Wild S.
Atypical forms of diabetes mellitus in Africans and other non-European
ethnic populations in low- and middle-income countries: a systematic
literature review. J Glob Health 2019;9(2):020401.
5. World Health Organization. Diabetes mellitus. Geneva (Switzerland):
WHO; 1985.
6. World Health Organization. Malnutrition fact sheet 2018 [Internet].
Available from: https://www.who.int/en/news-room/fact-sheets/detail/
malnutrition.
7. Fekadu S, Yigzaw M, Alemu S, Dessie A, Fieldhouse H, Girma
T, Trimble ER, Phillips DI, Parry EH. Insulin-requiring diabetes
in Ethiopia: associations with poverty, early undernutrition and
anthropometric disproportion. Eur J Clin Nutr 2010;64(10):1192–8.
8. van Abeelen AF, Elias SG, Bossuyt PM, Grobbee DE, van der Schouw
YT, Roseboom TJ, Uiterwaal CS. Famine exposure in the young
and the risk of type 2 diabetes in adulthood. Diabetes 2012;61(9):
2255–60.
9. Li Y, He Y, Qi L, Jaddoe VW, Feskens EJ, Yang X, Ma G,
Hu FB. Exposure to the Chinese famine in early life and the
risk of hyperglycemia and type 2 diabetes in adulthood. Diabetes
2010;59(10):2400–6.
10. Francis-Emmanuel PM, Thompson DS, Barnett AT, Osmond C, Byrne
CD, Hanson MA, Gluckman PD, Forrester TE, Boyne MS. Glucose
metabolism in adult survivors of severe acute malnutrition. J Clin
Endocrinol Metab 2014;99(6):2233–40.
11. PrayGod G, Changalucha J, Kapiga S, Peck R, Todd J, Filteau
S. Dysglycemia associations with adipose tissue among HIV-
infected patients after 2 years of antiretroviral therapy in Mwanza:
a follow-up cross-sectional study. BMC Infect Dis 2017;17(1):
103.
12. Brown NW, Ward A, Surwit R, Tiller J, Lightman S, Treasure JL,
Treasure JL, Campbell IC. Evidence for metabolic and endocrine
abnormalities in subjects recovered from anorexia nervosa. Metabolism
2003;52(3):296–302.
13. Kidola J, Filteau S, Faurholt-Jepsen D, Kitilya B, Kavishe B, Krogh-
Madsen R, Olsen MF, Changalucha J, Rehman AM, Range N,
et al. Diabetes prevalence by HbA1c and oral glucose tolerance
test among HIV-infected and uninfected Tanzanian adults. PLoS One
2020;15(4):e0230723.
14. PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-
Jepsen M, Aabye MG, Jensen L, Jensen AV, Grewal HM,
Magnussen P, et al. Daily multi-micronutrient supplementation
during tuberculosis treatment increases weight and grip strength among
HIV-uninfected but not HIV-infected patients in Mwanza, Tanzania. J
Nutr 2011;141(4):685–91.
15. PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen
M, Aabye MG, Jensen L, Jensen AV, Grewal HM, Magnussen P,
et al. The effect of energy-protein supplementation on weight, body
composition and handgrip strength among pulmonary tuberculosis HIV-
co-infected patients: randomised controlled trial in Mwanza, Tanzania.
Br J Nutr 2012;107(2):263–71.
16. Faurholt-Jepsen D, Range N, Praygod G, Jeremiah K, Faurholt-Jepsen
M, Aabye MG, Changalucha J, Christensen DL, Pipper CB, Krarup H,
et al. Diabetes is a risk factor for pulmonary tuberculosis: a case-control
study from Mwanza, Tanzania. PLoS One 2011;6(8):e24215.
17. Faurholt-Jepsen D, Range N, Praygod G, Jeremiah K, Faurholt-Jepsen
M, Aabye MG, Changalucha J, Ritz C, Christensen DL, Jørgensen ME,
et al. The association between conventional risk factors and diabetes is
weak among urban Tanzanians. Diabetes Care 2014;37(1):e5–6.
18. Filteau S, PrayGod G, Kasonka L, Woodd S, Rehman AM, Chisenga
M, Siame J, Koethe JR, Changalucha J, Michael D, et al. Effects on
mortality of a nutritional intervention for malnourished HIV-infected







/ajcn/advance-article/doi/10.1093/ajcn/nqaa438/6178919 by guest on 31 M
arch 2021
Prior malnutrition and insulin production 9
19. Woodd S, Kelly P, Koethe JR, PrayGod G, Rehman AM, Chisenga M,
Siame J, Heimburger DC, Friis H, Filteau S. Risk factors for mortality
among malnourished HIV-infected adults eligible for antiretroviral
therapy. BMC Infect Dis 2016;16:562.
20. Gibson RS. Principles of nutritional assessment. 2nd ed. Oxford (UK):
Oxford University Press; 2005.
21. World Health Organization. Definition and diagnosis of diabetes
mellitus and intermediate hyperglycaemia [Internet]. 2006. Available
from: http://www.who.int/diabetes/publications/diagnosis_diabetes200
6/en/.
22. Cersosimo E, Solis-Herrera C, Trautmann ME, Malloy J, Triplitt CL.
Assessment of pancreatic beta-cell function: review of methods and
clinical applications. Curr Diabetes Rev 2014;10(1):2–42.
23. Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB,
Boyko EJ, Leonetti DL, McNeely MJ, Fujimoto WY, Kahn SE. Oral
disposition index predicts the development of future diabetes above and
beyond fasting and 2-h glucose levels. Diabetes Care 2009;32(2):335–
41.
24. Lee N, White LV, Marin FP, Saludar NR, Solante MB, Tactacan-
Abrenica RJC, Suzuki M, Saito N, Ariyoshi K, Parry CM, et al. Mid-
upper arm circumference predicts death in adult patients admitted to
a TB ward in the Philippines: a prospective cohort study. PLoS One
2019;14(6):e0218193.
25. Ugarte-Gil C, Alisjahbana B, Ronacher K, Riza AL, Koesoemadinata
RC, Malherbe ST, Cioboata R, Llontop JC, Kleynhans L, Lopez S,
et al. Diabetes mellitus among pulmonary tuberculosis patients from
4 tuberculosis-endemic countries: the TANDEM study. Clin Infect Dis
2020;70(5):780–8.
26. Njuguna B, Kiplagat J, Bloomfield GS, Pastakia SD, Vedanthan
R, Koethe JR. Prevalence, risk factors, and pathophysiology of
dysglycemia among people living with HIV in sub-Saharan Africa. J
Diabetes Res 2018;2018:1.
27. World Health Organization. Global Physical Activity Questionnaire
(GPAQ) 2006 [Internet]. Available from: http://www.who.int/chp/step
s/resources/GPAQ_Analysis_Guide.pdf?ua=1.
28. Woodd SL, Kelly P, Koethe JR, Praygod G, Rehman AM, Chisenga M,
Siame J, Heimburger DC, Friis H, Filteau S. Risk factors for mortality
among malnourished HIV-infected adults eligible for antiretroviral
therapy. BMC Infect Dis 2016;16(1):562.
29. Thurner S, Klimek P, Szell M, Duftschmid G, Endel G, Kautzky-Willer
A, Kasper DC. Quantification of excess risk for diabetes for those born
in times of hunger, in an entire population of a nation, across a century.
Proc Natl Acad Sci 2013;110(12):4703–7.
30. Hult M, Tornhammar P, Ueda P, Chima C, Bonamy AK, Ozumba B,
Norman M. Hypertension, diabetes and overweight: looming legacies
of the Biafran famine. PLoS One 2010;5(10):e13582.
31. Case A, Menendez A. Sex differences in obesity rates in poor
countries: evidence from South Africa. Econ Hum Biol 2009;7(3):
271–82.
32. NCD Risk Factor Collaboration (NCD-RisC)–Africa Working Group.
Trends in obesity and diabetes across Africa from 1980 to 2014:
an analysis of pooled population-based studies. Int J Epidemiol
2017;46:1421–32.
33. Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences
in risk, pathophysiology and complications of type 2 diabetes mellitus.
Endocr Rev 2016;37(3):278–316.
34. Kotler DP, Thea DM, Heo M, Allison DB, Engelson ES, Wang J,
Pierson RN Jr, Heymsfiel SB, Lederman SA. Relative influences of sex,
race, environment, and HIV infection on body composition in adults.
Am J Clin Nutr 1999;69(3):432–9.
35. Mupere E, Malone L, Zalwango S, Okwera A, Nsereko M, Tisch DJ,
Parraga IM, Stein CM,, Mugerwa R, Boom WH, et al. Wasting among
Uganda men with pulmonary tuberculosis is associated with linear
regain in lean tissue mass during and after treatment in contrast to
women with wasting who regain fat tissue mass: prospective cohort
study. BMC Infect Dis 2014;14:24.
36. PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-
Jepsen M, Aabye MG, Yilma D, Girma T, Tesfaye M, Andersen ÅB,
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